Novo to spend 265 million of Wegovy’s revenues on respiratory diseases

The Novo Nordisk Foundation, which controls drug maker Novo Nordisk, said Monday the government will allocate up to 1.8 billion Danish kroner ($265 million) for an initiative aimed at improving vaccines against respiratory diseases.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM